Item 2.02. Results of Operations and Financial Condition.
On November 9, 2020, Cara Therapeutics, Inc. (the "Company") issued a press
release announcing its financial results for the third quarter ended September
30, 2020. A copy of the press release is being furnished to the Securities and
Exchange Commission as Exhibit 99.1 to this Current Report on Form 8-K and is
incorporated by reference to this Item 2.02.
The information furnished pursuant to this Item 2.02, including Exhibit 99.1,
shall not be deemed to be "filed" for purposes of Section 18 of the Securities
Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the
liabilities of that section, nor shall it be deemed to be incorporated by
reference into any of the Company's filings with the Securities and Exchange
Commission under the Exchange Act or the Securities Act of 1933, as amended,
whether made before or after the date hereof, regardless of any general
incorporation language in such a filing.
Item 9.01. Financial Statements and Exhibits.
Exhibit No. Description
99.1 Press Release dated November 9, 2020
Cover page interactive data file (formatted as Inline XBRL)
© Edgar Online, source Glimpses